search
NASDAQ:PRLD
USD
0.818
- (7%)
PRELUDE THERAPEUTICS INCORPORATED
Industry: Biotechnology
End of Day: 8 May 2025 GMT-4
USD 0.818
- (7.0%)
End of Day: 8 May 2025 GMT-4
Industry: Biotechnology

Quote

Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-

Company Info

more

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with ...

Key Ratios

more

Income

more

Balance Sheet

more

Cash Flow

more

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices